Inflation Pressures Widen Beyond Oil and Iran Housing Food and Services Show Price Acceleration UltraRich in Germany Control Over 25 of Financial Wealth BCG Report Reveals Oil Prices Plunge Over 5 as Iran Nuclear Deal Hopes Resurface Moroccos Tourism Push in Western Sahara Economic Opportunity or Political Leverage Spotify Shares Surge on AI Music Deal with Universal Music LongTerm Growth Guidance Prediction Market Investments Continue as Companies Navigate Evolving Regulatory Environment Hillman Solutions HLMN Q1 2026 Earnings EPS Falls Short Amid Challenging Environment QH Q4 2021 Earnings Staggering EPS Miss Exposes Deep Operational Challenges TPR Q1 2026 Earnings EPS Exceeds Estimates by 26 Air T Inc AIRT Q1 2026 Earnings Strong EPS Performance Drives Stock Higher WKHS Q1 2026 Earnings Deepening Losses Amid Operational Transition COST Q1 2026 Earnings EPS Misses Estimates as Membership Model Faces Margin Pressure MSAIW Warrants Hold Steady at 003 Amid Low Activity What This Means for Investors Mexico Fund Inc MXF Surges 175 Above Support Testing Key Resistance at 2318 PC Connection CNXN Holds Near 6650 as Consolidation Persists Nuveen California Municipal Income Fund NKX Records Modest Gain as Yield Environment Stabilizes Enterprise Products Partners EPD Pulls Back 1 as Support and Resistance Levels Come into Focus Mortgage Rates Mixed 30Year Fixed Declines 15Year Fixed and ARMs Move in Opposite Directions Perrigo Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction Telephone and Data Systems TDS Posts Minor Gain Key Levels in Focus AMBP Q1 2026 Earnings Strong EPS Beat Overshadowed by Market Headwinds RITM Q1 2026 Earnings Modest EPS Beat Highlights Steady Portfolio Performance LIND Q1 2026 Earnings Significant EPS Beat Drives Stock Higher PNR Q1 2026 Earnings EPS Beats Estimates by 33 as Shares Slip Slightly CNI Q1 2026 Earnings EPS Slightly Beats Estimates Amid Stable Operations Trane Technologies Q1 2026 Earnings EPS Beat Drives Modest Share Gains Amid Steady Operational Execution RenovoRx Q1 2026 Earnings EPS Miss as PreRevenue Biotech Continues Clinical Development